Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
7.43
+0.02 (0.27%)
Jun 27, 2025, 2:45 PM CST
Guangdong VTR Bio-Tech Revenue
Guangdong VTR Bio-Tech had revenue of 202.40M CNY in the quarter ending March 31, 2025, with 1.79% growth. This brings the company's revenue in the last twelve months to 829.76M, up 1.94% year-over-year. In the year 2024, Guangdong VTR Bio-Tech had annual revenue of 826.20M with 3.79% growth.
Revenue (ttm)
829.76M
Revenue Growth
+1.94%
P/S Ratio
4.28
Revenue / Employee
752.96K
Employees
1,102
Market Cap
3.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
Dec 31, 2020 | 1.91B | -133.37M | -6.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |